Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Q32 Bio Inc. Director's Dealing 2025

Dec 5, 2025

34891_dirs_2025-12-04_6543f0c7-5429-41f4-ac99-d32f69510758.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Q32 Bio Inc. (QTTB)
CIK: 0001661998
Period of Report: 2025-12-02

Reporting Person: Kalowski Lee (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-12-02 Common Stock S 9072 $3.4607 Disposed 39938 Direct